Becton Dickinson and Co vs Amplify Cybersecurity ETF — how do they compare? Becton Dickinson and Co trades at $156.31 (market cap $41.51B), while Amplify Cybersecurity ETF trades at $112.97. The key difference: Becton Dickinson and Co pays a 2.79% dividend while Amplify Cybersecurity ETF pays none, and Amplify Cybersecurity ETF is trading nearer its 52-week high, Becton Dickinson and Co nearer its low. Which is the better fit depends on your goals.
| BDX | HACK | |
|---|---|---|
Market Cap | $41.51B | — |
Sector | Health | Sector/Thematic |
52-Week High | $185.39 | $114.29 |
52-Week Low | $135.49 | $70.69 |
Enterprise Value | $57.97B | — |
Dividend Yield | 2.79% | — |
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
HACK trades at $109.28, up 0.28% with a bullish technical outlook supported by strong moving average signals. The cybersecurity ETF benefits from growing sector spending exceeding $300 billion in 2026 and recent momentum hitting 52-week highs. However, overbought RSI readings suggest potential near-term consolidation. The fund captures the expanding cybersecurity market driven by AI-powered threats and increased enterprise security budgets.
The outlook remains positive as cybersecurity becomes essential infrastructure, though elevated valuations and technical overbought conditions present near-term risks. Long-term growth drivers include AI-driven security demands and regulatory compliance requirements, but sector competition and market volatility could pressure returns.
Trailing returns across standard periods
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →HACK provides diversified exposure to the global cybersecurity industry. It invests across the full value chain, including hardware, software, and consulting services, with key holdings in firms like Broadcom, Cisco, and Palo Alto Networks.
Read more on HACK →